Smartleaf Asset Management »

Ishares Tr genomics immun shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6k 110 23.30

More positions owned by Smartleaf Asset Management

Vanguard World Mega Cap Val Etf (MGV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Wisdomtree Tr Mortgage Plus Bd (MTGP)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)

View all positions for Smartleaf Asset Management

Top funds holding Ishares Tr genomics immun

Jane Street
Wharton Business Group
Bank of America Corporation
UBS Group
Royal Bank of Canada
Bsc Private Wealth Management
Commonwealth Equity Services
Advisor Group Holdings
Cora Capital Advisors
Citadel Advisors
Visionary Wealth Advisors
Raymond James Financial Services Advisors
Branch Banking & Trust Company
TCG Advisory Services
PFG Investments

View all funds holding Ishares Tr genomics immun